← Back to Clinical Trials
Recruiting NCT07531810

NCT07531810 Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07531810
Status Recruiting
Phase
Sponsor Cumhuriyet University Hospital
Condition Nasal Deformity
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2026-03-24
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2026-03-24 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Structural rhinoplasty with septal extension graft (SEG) is commonly used to achieve stable nasal tip support and predictable long-term outcomes. However, surgical success is not limited to structural stability alone and should also be evaluated from the patient's perspective. Patient-reported outcome measures (PROMs) have gained increasing importance in rhinoplasty, as they reflect patient satisfaction and perceived nasal function. Despite the widespread use of SEG, prospective studies evaluating PROMs together with postoperative clinical findings over time remain limited. This prospective observational cohort study aims to evaluate longitudinal changes in patient-reported outcomes and postoperative findings in adult patients undergoing primary structural rhinoplasty with SEG-based nasal tip support. Validated PROM instruments will be applied preoperatively and during routine postoperative follow-up visits at approximately 1, 3, and 6 months. In addition, postoperative complications and revision procedures will be recorded. The study aims to provide a more comprehensive understanding of patient-centered outcomes and their relationship with clinical findings in SEG-based rhinoplasty.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Undergoing primary structural rhinoplasty with septal extension graft * Able to understand and complete patient-reported outcome questionnaires (PROMs) * Willing to participate and provide written informed consent Exclusion Criteria: * History of previous nasal surgery (revision rhinoplasty) * Undergoing concomitant major craniofacial procedures * Missing preoperative PROM data * Unable to complete postoperative follow-up assessments

Contact & Investigator

Central Contact

Murat Çelik, Assistant Professor

✉ mucetr@gmail.com

📞 +905546902104

Principal Investigator

Murat Çelik, Assistant Professor

PRINCIPAL INVESTIGATOR

Cumhuriyet University

Frequently Asked Questions

Who can join the NCT07531810 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Nasal Deformity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07531810 currently recruiting?

Yes, NCT07531810 is actively recruiting participants. Contact the research team at mucetr@gmail.com for enrollment information.

Where is the NCT07531810 trial being conducted?

This trial is being conducted at Sivas, Turkey (Türkiye).

Who is sponsoring the NCT07531810 clinical trial?

NCT07531810 is sponsored by Cumhuriyet University Hospital. The principal investigator is Murat Çelik, Assistant Professor at Cumhuriyet University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology